Skip to content
  • Saturday, 22 August 2026
  • 7:51 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Stanford Researchers Discover Protein Inhibitor That Reverses Cartilage Loss and Prevents Osteoarthritis
Stem Cell & Regenerative Medicine

Stanford Researchers Discover Protein Inhibitor That Reverses Cartilage Loss and Prevents Osteoarthritis

Dwi Wanna Jul 20, 2026 0

In a breakthrough that could fundamentally alter the treatment landscape for degenerative joint diseases, researchers at Stanford Medicine have identified…

Read More
Environmental & Analytical Chemistry

The Surface Geometry of Gold Prevents Oxidation by Rearranging Atoms

Abdurrohim Arsyad May 22, 2026 0

Gold, a metal renowned for its enduring luster and resistance to environmental degradation, owes its remarkable stability to a subtle…

Read More
The Unveiling of Life’s Trajectory: Midlife Behaviors as Predictors of LongevityNovo Nordisk sues Hims for GLP-1 patent infringementGut-Brain Signaling Pathways Reveal Distinct Neural Responses to Fructose and Glucose IntakeExpanding Screening for Type 1 Diabetes in Children Could Identify More Cases
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ